- Global Pharma News & Resources

Press Releases - 2022-05-18

Date Title Company
18-May-2022 MorphoSys AG Reports Outcome of Annual General Meeting 2022 MorphoSys AG
18-May-2022 Ion Mobility Spectrometry Market | Global Industry Report, 2029 MARKITWIRED
18-May-2022 Pancreatic Cyst Diagnostics Market Analysis by Trends, Report to 2029 MARKITWIRED
18-May-2022 Fluorescence Spectroscopy Market Size, Share Analysis Report to 2028 MARKITWIRED
18-May-2022 Cardiometabolic Drugs Market Estimated to Surpass a Valuation of US$ 70 Billion by 2032, Rising at a CAGR of 4% to 5% During The Forecast Period 2022-2032 MARKITWIRED
18-May-2022 Autoclaves Market is Expected to Reach 5.3% CAGR by The End of 2030 MARKITWIRED
18-May-2022 Vaginitis Treatment Drugs Market is Expected to Progress at 5.2% CAGR to Reach US$ 4.52 Billion by The End of 2030 MARKITWIRED
18-May-2022 Donor Egg IVF (In-Vitro Fertilization) Market is Projected to Grow at a Robust CAGR of 7.7% Between 2022 -2028 MARKITWIRED
18-May-2022 Gait Trainer Market is Predicted to Exhibit Progression at a Modest CAGR of 4.9% Over The Forecast Period 2022 – 2028 MARKITWIRED
18-May-2022 Medacta opens new offices in Rancate, Switzerland Medacta Group SA
18-May-2022 ABIVAX: Abivax announces annual ordinary and extraordinary general meeting on June 9, 2022, and the availability of the preparatory documents ABIVAX
18-May-2022 U.S. Digital Pregnancy Test Kits Market Projected to Rise at a 6.0% CAGR between 2021 and 2031 MARKITWIRED
18-May-2022 GCC Medical Gloves Market Expanding at a 7.9% CAGR, Market Valuation Projected to Reach US$ 340.3 Million by 2031 MARKITWIRED
18-May-2022 Magnetic Resonance Makes the Invisible Visible University of Vienna
18-May-2022 Biotage Launches New High Volume Automated Sample Preparation Workstation Biotage
18-May-2022 Successful Completion of Phase I Study for Lead Asset EP395 EpiEndo Pharmaceuticals
18-May-2022 Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo Almirall
18-May-2022 BioMed X Institute Launches Ukraine Refugee Funding Program BioMed X
18-May-2022 Syncona invests in $56 million Series B financing of SwanBio Therapeutics Syncona
18-May-2022 Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award Vetter